Olon to expand Settimo Torinese location, as company adds protein production to repertoire
CDMO’s objective is to cater to various market segments in order to meet microbial bio-manufactured compound demand
Olon Group is expanding its Italian site located in Settimo Torinese, a place that the active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) says is an asset of the global manufacturing network.
The company will be designing and operating the new area with advanced technologies that, relying on biomanufacturing knowledge, will produce proteins following highly sustainable processes, including microbial fermentation.
The expansion will allow Olon to increase its capacity to accommodate new and existing clients' needs, as it fits in the strategy of expanding the CDMO services in different market segments.
"We are significatively investing in our fermentation capacity following market trends that show an increased demand for microbial bio-manufactured compounds,” says Paolo Tubertini, Olon Group CEO. “Offering our expertise in CDMO services and biotechnological platforms as well, we are able to support innovative biotech companies to accelerate the development of new products, combining it with a more sustainable manufacturing approach."
Antares Vision Group, Siempharma Strike Up Pharma Labeling Equipment Collaboration
May 8th 2025The track-and-trace systems provider expands its life sciences portfolio by integrating the high-speed, adaptable ETF-300 precision labeler through a partnership that brings Industry 4.0-ready capabilities, advanced printing tech, and enhanced data security to pharmaceutical packaging.
